What is the current Price Target for the 180 Life Sciences Corp stock?

The average 180 Life Sciences Corp target price is $81.60. This is 9,172.73% higher than the current stock price. The highest price target is 9,445.45%, the lowest is 9,081.82%. 3 Analysts have issued a price target 180 Life Sciences Corp 2026 .

How high will the 180 Life Sciences Corp stock rise?

No reliable answer can be given as to how high the 180 Life Sciences Corp stock will rise. The performance of stocks, including the 180 Life Sciences Corp stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the 180 Life Sciences Corp stock today?

The performance of 180 Life Sciences Corp stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the 180 Life Sciences Corp stock fall?

The decline in 180 Life Sciences Corp stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

180 Life Sciences Corp Forecast, price target & analysts

$0.88

1.93%

Nasdaq, Jul 03, 10:28 pm CET

ISIN

US68236V1044

Symbol

ATNF

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

180 Life Sciences Corp Target price 2025 - Analyst rating & recommendation

180 Life Sciences Corp Classifications & Recommendation:

Buy

86%

Hold

14%

180 Life Sciences Corp Price Target

Target Price	$81.60
Price	$0.88
Potential	9,172.73% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target 180 Life Sciences Corp 2026 . The average 180 Life Sciences Corp target price is $81.60. This is 9,172.73% register free of charge higher than the current stock price. The highest price target is $84.00 9,445.45% register free of charge , the lowest is $80.80 9,081.82% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend 180 Life Sciences Corp to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the 180 Life Sciences Corp stock has an average upside potential 2026 of 9,172.73% register free of charge . Most analysts recommend the 180 Life Sciences Corp stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-15.49	-3.06
	70.55%	80.25%
P/E		negative
EV/Sales		0.14

3 Analysts have issued a 180 Life Sciences Corp forecast for earnings per share. The average 180 Life Sciences Corp EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-15.49	70.55%
2025	$-3.06 80.25% Unlock

Current	-0.20	210.32%
2025	-0.29 43.99% Unlock

180 Life Sciences Corp...

Discover more stocks with a high price target

Alibaba Group Holding Ltd 55.07%

Tencent Holdings Ltd. 30.37%

Adyen 29.68%

Adidas 29.43%

BioNTech SE - ADR 27.50%

Deutsche Telekom 25.72%

Siemens 15.22%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now